Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

GENEGENE
Showing 8 of 13 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in GENETIC TECHNOLOGIES LTD

RHUMBLINE ADVISERS holds 2,650 shares of GENE (GENETIC TECHNOLOGIES LTD), worth $2,026 as of 2026-Q2.

Current Value

$2,026

Current Shares

2,650

Total Value Change

-$769

Total Shares Change

-1,089

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
2,650
0.0%
$2,0260.0%—
0
2026-Q1
Unchanged
2,650
0.0%
$2,0260.0%—
0
2025-Q4
Unchanged
2,650
0.0%
$2,0260.0%—
0
2025-Q3
Decreased
2,650
-20.7%
$2,0260.0%—
0
2025-Q2
Decreased
3,340
-10.7%
$2,5530.0%—
0
2025-Q1
Unchanged
3,739
0.0%
$6970.0%—
0
2024-Q4
Unchanged
3,739
0.0%
$2,8580.0%—
0
2024-Q3
Unchanged
3,739
0.0%
$2,7950.0%—
0

Other major holders of GENE: SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, GROUP ONE TRADING LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used